Fractyl Health, Inc. (GUTS) vs MiNK Therapeutics, Inc. (INKT)

A side-by-side comparison of Fractyl Health, Inc. and MiNK Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Fractyl Health, Inc. logo
GUTS
Fractyl Health, Inc.
$62M
$4.68HealthcareDelayed quote: Oct 6, 2026, 2:50 PM EDT
MiNK Therapeutics, Inc. logo
INKT
MiNK Therapeutics, Inc.
$59M
$11.83HealthcareDelayed quote: Oct 6, 2026, 2:49 PM EDT

Total return — GUTS vs INKT

growth of $100 · dividends reinvested · last 3y
GUTS -97.0% (-69.1%/yr)INKT +35.7% (+10.7%/yr)INKT compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020252026$3$136
GUTS INKT

GUTS vs INKT: by the numbers

  • •GUTS is the larger company ($62M vs $59M market cap).

Metrics side by side

Profitability

MetricGUTSINKT
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROIC-129.67%-604.20%

Go deeper

Full GUTS analysisFull INKT analysisInteractive comparison tool

Dig into the metrics

Fractyl Health ROEMiNK Therapeutics ROEFractyl Health operating marginMiNK Therapeutics operating marginFractyl Health revenue growthMiNK Therapeutics revenue growthFractyl Health free cash flowMiNK Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.